Cojocaru, I.; Guliciuc, M.; Cojocaru, E.; Serban, C.; Pascaru, G.; Borz, M.B.; Schitcu, V.H.; Tise, A.-I.; Osoianu, I.; Rebegea, L.-F.
A Review of the Latest Evidence on Prognostic Factors in Locally Advanced and Metastatic Urothelial Carcinoma Treated with Immune Checkpoint Inhibitors. Medicina 2026, 62, 46.
https://doi.org/10.3390/medicina62010046
AMA Style
Cojocaru I, Guliciuc M, Cojocaru E, Serban C, Pascaru G, Borz MB, Schitcu VH, Tise A-I, Osoianu I, Rebegea L-F.
A Review of the Latest Evidence on Prognostic Factors in Locally Advanced and Metastatic Urothelial Carcinoma Treated with Immune Checkpoint Inhibitors. Medicina. 2026; 62(1):46.
https://doi.org/10.3390/medicina62010046
Chicago/Turabian Style
Cojocaru, Ion, Mădălin Guliciuc, Elena Cojocaru, Cristina Serban, Grigore Pascaru, Mihnea Bogdan Borz, Vlad Horia Schitcu, Andrei-Ionut Tise, Iulian Osoianu, and Laura-Florentina Rebegea.
2026. "A Review of the Latest Evidence on Prognostic Factors in Locally Advanced and Metastatic Urothelial Carcinoma Treated with Immune Checkpoint Inhibitors" Medicina 62, no. 1: 46.
https://doi.org/10.3390/medicina62010046
APA Style
Cojocaru, I., Guliciuc, M., Cojocaru, E., Serban, C., Pascaru, G., Borz, M. B., Schitcu, V. H., Tise, A.-I., Osoianu, I., & Rebegea, L.-F.
(2026). A Review of the Latest Evidence on Prognostic Factors in Locally Advanced and Metastatic Urothelial Carcinoma Treated with Immune Checkpoint Inhibitors. Medicina, 62(1), 46.
https://doi.org/10.3390/medicina62010046
